Trending News

Changes to Civil Rights Enforcement: New Executive Order Eliminates Disparate-Impact Liability in Federal Regulations

How Are Family Offices Building Smarter Wealth? Structural Alpha (11 Examples)

DOJ Rule Restricting Sensitive Data Transfers Takes Effect

The Trump Administration’s Diversity, Equity, and Inclusion (DEI) Executive Orders: A Brief Primer

Trump Administration Announces "Reciprocal" Tariffs

What Every Multinational Company Should Know About … The Global and Reciprocal Tariffs Announcement

Blockading the Ports: U.S. Imposes 10% Global Tariff; Higher Reciprocal Tariff Rates by Country

Fifth Circuit Court of Appeals Negates Ruling on Federal Contractor Minimum Wage

New Executive Order Rescinds the $17.75 Per Hour Federal Contractor Minimum Wage

Medicare Telehealth Gets Another Temporary Lifeline – Will Congress Make it Permanent?

GlobeNewswire Biotech

Website

www.globenewswire.com

Featured Biotech Press Releases From GlobeNewswire

Sixty Degrees Pharmaceuticals Announces Patent License Agreement to Advance Development of Tafenoquine for Babesiosis Treatment and Prevention with Yale School of Medicine and Yale School of Public Health
Posted On Tuesday, April 08, 2025
Onconetix Signs Letter of Intent for Potential Business Combination with Ocuvex Therapeutics, Inc.
Posted On Tuesday, April 08, 2025
Ocugen to Present at the 2025 Cell & Gene Meeting on the Med
Posted On Tuesday, April 08, 2025
Aemetis Biogas Monthly RNG Production Increased by 55% in March
Posted On Tuesday, April 08, 2025
BioStem Technologies to Host Fourth Quarter and Full Year 2024 Financial Results Conference Call on April 14, 2025
Posted On Tuesday, April 08, 2025
Myricx Bio Announces Expansion of its Leadership Team to Advance NMTi-ADCs into Clinical Development
Posted On Tuesday, April 08, 2025
Lipella Pharmaceuticals Completes Enrollment in Phase 2a Trial of LP-310 for Oral Lichen Planus
Posted On Tuesday, April 08, 2025
Tanke Biosciences Corp Announces the Appointment of John P. Hopkins Executive Chairman of the Board of Directors
Posted On Monday, April 07, 2025
Avicanna Announces Receipt of Management Cease Trade Order and Provides Bi-Weekly Status Update
Posted On Monday, April 07, 2025
Pacira BioSciences Announces Settlement of U.S. Patent Litigation for EXPAREL
Posted On Monday, April 07, 2025
Jeune Aesthetics Appoints Marc Forth as Chief Executive Officer
Posted On Monday, April 07, 2025
Monthly information on share capital and company voting rights
Posted On Monday, April 07, 2025
Oragenics, Inc. Participates in the 3rd Nasal Formulation & Delivery Summit
Posted On Monday, April 07, 2025
Organogenesis Holdings Inc. to Report First Quarter of Fiscal Year 2025 Financial Results on May 8, 2025
Posted On Monday, April 07, 2025
Pliant Therapeutics Announces Upcoming Presentations at the 2025 American Thoracic Society International Conference
Posted On Monday, April 07, 2025
AIM ImmunoTech Announces Trading Under the Ticker AIMI on the Pink Open Market
Posted On Monday, April 07, 2025
Adaptin Bio, Inc., a Lucius Partners Portfolio Company, Completes Alternative Public Offering (APO) and Closes $7.7 Million Private Placement
Posted On Monday, April 07, 2025
ImmuCell Hires Chief Financial Officer
Posted On Monday, April 07, 2025
Rectify Pharma Announces Publication of BSEP Transporter Biophysical Characterization in Communications Biology
Posted On Monday, April 07, 2025
Better Choice Company Issues Stock Dividend of 0.35 per Share for Each Share Held for Stockholders of Record as of April 17, 2025
Posted On Monday, April 07, 2025
Senti Bio Joins Webull Corporate Connect Service Platform
Posted On Monday, April 07, 2025
Allogene Granted Three U.S. FDA Fast Track Designations (FTD) for ALLO-329, a Next-Generation Dual-Targeted CD19/CD70 Allogeneic CAR T, for the Treatment of Lupus, Myositis and Scleroderma
Posted On Monday, April 07, 2025
NKGen Biotech Presents Data from Phase 1/2a Clinical Trial of Troculeucel in Moderate Alzheimer’s Disease at the International Conference on Alzheimer’s and Parkinson’s Diseases (AD/PD™ 2025)
Posted On Monday, April 07, 2025
MBX Biosciences Appoints Veteran Pharmaceutical Executive Steve Hoerter to Board of Directors
Posted On Monday, April 07, 2025
ALX Oncology Receives IND Clearance from U.S. FDA for ALX2004, a Novel EGFR-targeted Antibody-drug Conjugate
Posted On Monday, April 07, 2025

Print